Navigation Links
Dasatinib Shows High Early Response Rate as First Treatment for,Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report

CHICAGO, June 2, 2007 - An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.

"Patients taking dasatinib achieve complete cytogenetic response - absence of the mutated protein that drives this disease - more rapidly than we've observed historically using the current front-line therapy. Side effects are very manageable," says Ehab L. Atallah, M.D., lead author of the study and a fellow in M. D. Anderson's Department of Leukemia. Atallah presented study results at the annual meeting of the American Society of Clinical Oncology in Chicago Saturday June 2nd, 2007. The clinical trial remains in progress with 35 patients enrolled.

Dasatinib, known commercially as Sprycel and produced by Bristol-Myers Squibb, was approved by the U.S. Food and Drug Administration a year ago for use by patients whose disease is unresponsive to or becomes resistant to the front-line therapy imatinib. Both drugs bind to and block a genetically flawed protein known as BCR-ABL, which causes the disease. Atallah explains that dasatinib binds to both forms BCR-ABL while imatinib blocks only one.

"Our hypothesis is that treating with dasatinib first will produce an earlier response, which may translate to a better overall survival," Atallah says. "We haven't proved that here, but these early results are encouraging."

Atallah and colleagues evaluated 35 patients who enrolled in the clinical trial between November 2005 and December 2006. Patients receive either 100 mg of dasatinib once daily or 50 mg twice daily.

Thirty four patients had been on the clinical trial for at least three months when Atallah and lead researcher Jorge Cortes, M.D., professor in the Department of Leukemia, eva
'"/>




Page: 1 2 3

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:7/25/2014)... 2014  In today,s marketplace, launching multiple products for ... as is managing a portfolio of products in the ... - or even preferable - to pool resources to ... combine resources and activities, and what marketing and sales ... just a few of the dilemmas facing pharmaceutical sales, ...
(Date:7/25/2014)... MISSION, Kan. , July 25, 2014 /PRNewswire-iReach/ ... , and TCGRx, of Powers Lake, ... exclusive partners in a distribution and co-marketing agreement ... to retail pharmacies throughout the United ... of robotics-based pharmacy management and workflow systems to ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, ... Tobago Ministry of Health approved the introduction of ... increases the cure rate from Hepatitis C, and ... genotype 1 virus. Telaprevir is available in ... INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
Breaking Medicine Technology:Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3
... and INGELHEIM, Germany, July 6, 2011 As part ... the most promising solutions to challenging health problems around ... the launch of the Making More Health: Achieving ... This worldwide competition invites the most ...
... Inc. (NYSE: RMD and ASX: ... medical equipment for treating, diagnosing and managing sleep-disordered ... it has acquired BiancaMed Ltd., a leading Irish ... outstanding shares with cash.   (Logo: ...
Cached Medicine Technology:Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 2Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 3ResMed Announces Acquisition of BiancaMed 2ResMed Announces Acquisition of BiancaMed 3
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, ... policy that bans blood donations from gay and bisexual men, according ... in the Journal of the American Medical Association . ... cannot donate blood in the United States -- a lifetime ban ... and Drug Administration adopted this policy at the dawn of the ...
(Date:7/28/2014)... a healthy lifestyle may help childhood cancer survivors reduce ... indicates. Researchers suggested that children with cancer and ... about how their diet and certain behaviors could ... are important because they indicate that adults who were ... influence their own health outcomes," said one of the ...
(Date:7/28/2014)... "We experienced difficulty filling our pill ... two inventors from Jamestown, Calif. "We came up with ... we could pour medications in more easily." , They ... keep the lids open as the pill box is ... compartments have been filled. This eliminates hassles and frustrations, ...
(Date:7/28/2014)... 28, 2014 Scientists in Japan have ... improved blood test for the asbestos cancer mesothelioma. Surviving ... research. Click here to read it now. ... Tokyo’s Juntendo University Graduate School of Medicine say a ... a step above the old test. , “Particularly ...
(Date:7/28/2014)... Hill, South Carolina (PRWEB) July 28, 2014 ... people enjoy their first bite of food best, with ... before. Over-indulging, the researchers found, can actually serve to ... to overindulge in foods they enjoy, not realizing the ... statement. "This is the argument for moderation, if we ...
Breaking Medicine News(10 mins):Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 2Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 3Health News:Healthy Habits May Help Childhood Cancer Survivors Avoid Chronic Ills 2Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3
... MIAMI, Oct. 8 Infants and toddlers cannot ... on over-the-counter children,s,medicines, parents need a safe alternative ... been the bulb aspirator. However, these can,irritate a ... In-the-know parents have discovered the safe, effective alternative,that,s ...
... treatment for breast cancer differs between African-American women and ... insurance type. The study appears in the November 15, ... American Cancer Society. , Dr. Mousumi Banerjee of ... from Wayne State University and Dr. William Hryniuk from ...
... progression of age-related macular degeneration (AMD), according to a ... Human Nutrition Research Center on Aging at Tufts University. ... in 7 to 15% of the elderly, according to ... be the most practical and cost-effective prevention method to ...
... BEND, Ind., Oct. 7 OCS, Inc. and,Press ... into a,partnership, whereby the companies have combined their ... of products for the home,health care industry. The ... analysis of interrelated performance metrics integrating,patient satisfaction, patient ...
... The following is a,transcript of a radio address by ... morning., One important commitment of the Federal government ... care. Most of these children are,covered by Medicaid, which ... fiscal year. For children who do not qualify for ...
... Studies link this common problem with vascular disease , , ... realize it, but if they,re having problems achieving or ... Erectile dysfunction, or impotence, affects more than 18 million ... at the Johns Hopkins Bloomberg School of Public Health. ...
Cached Medicine News:Health News:As Cold & Flu Season Nears, New Baby Nasal Aspirator Offers Safe and Effective Alternative to FDA-Discouraged Medicines 2Health News:Differences observed between black and white women in use of breast cancer therapy 2Health News:Limiting refined carbohydrates may stall AMD progression 2Health News:OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction 2Health News:Radio Address by President Bush to the Nation 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 3
The Achieva CV brings the power of CMR into routine clinical practice, so you can do more in Cardiovascular MR....
The Clearblue Easy Digital Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the...
These products are primarily for use with paediatric patients and for patients with difficult veins....
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: